In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligandChristopher J. Nicolai, Byoung Y. Ryu, Maura H. Parker et al.|Blood|2024Cited by 102
Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T CellsMalika Hale, David J. Rawlings, Baeckseung Lee et al.|Molecular Therapy — Methods & Clinical Development|2017Cited by 71
Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activationWai‐Hang Leung, Wing Leung, Queenie Vong et al.|The Journal of Experimental Medicine|2013Cited by 58
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosingJacob Appelbaum, Michael C. Jensen, Semanti Sarkar et al.|Journal of Clinical Investigation|2024Cited by 51
1230 VivoVec lentiviral vector particles surface-engineered with T cell activating and co-stimulatory ligands enhance<i>in vivo</i>CAR T cell generation and antitumor activityChris Nicolai, Wai‐Hang Leung, Jim Qin et al.|Regular and Young Investigator Award Abstracts|2022Cited by 0